Dupilumab (Sanofi) cemented its position as the top-selling inflammatory illness medication with its first-in-class ... interaction and lowers eosinophil counts in severe asthma/EGPA. Benralizumab ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA).

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Review the current AstraZeneca PLC ADR (AZN:XNAS) dividend yield and history to decide if AZN is the best investment for you.